These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16971349)

  • 1. The "oil well analogy" as a comprehensive interpretation of factors leading to muscle injury and wasting.
    Orozco-Levi M; Lloreta J; Gea J
    Ultrastruct Pathol; 2006; 30(4):247-52. PubMed ID: 16971349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathophysiology of cachexia in chronic obstructive pulmonary disease.
    Schols AM; Gosker HR
    Curr Opin Support Palliat Care; 2009 Dec; 3(4):282-7. PubMed ID: 19713853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle response to inflammation--lessons for chronic obstructive pulmonary disease.
    Reid WD; Rurak J; Harris RL
    Crit Care Med; 2009 Oct; 37(10 Suppl):S372-83. PubMed ID: 20046123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms and treatment options for muscle wasting diseases.
    Rüegg MA; Glass DJ
    Annu Rev Pharmacol Toxicol; 2011; 51():373-95. PubMed ID: 20936944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting.
    Debigaré R; Maltais F; Côté CH; Michaud A; Caron MA; Mofarrahi M; Leblanc P; Hussain SN
    COPD; 2008 Apr; 5(2):75-84. PubMed ID: 18415806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity.
    Remels AH; Gosker HR; van der Velden J; Langen RC; Schols AM
    Clin Chest Med; 2007 Sep; 28(3):537-52, vi. PubMed ID: 17720042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular and biological research on respiratory muscle wasting in chronic obstructive pulmonary disease].
    Ju CR; Chen RC
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):613-5. PubMed ID: 17988560
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic approaches for muscle wasting disorders.
    Lynch GS; Schertzer JD; Ryall JG
    Pharmacol Ther; 2007 Mar; 113(3):461-87. PubMed ID: 17258813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of muscle size during disuse, disease, and aging.
    Degens H; Alway SE
    Int J Sports Med; 2006 Feb; 27(2):94-9. PubMed ID: 16475053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease. 5: systemic effects of COPD.
    Wouters EF
    Thorax; 2002 Dec; 57(12):1067-70. PubMed ID: 12454303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle wasting in cardiac cachexia.
    Strassburg S; Springer J; Anker SD
    Int J Biochem Cell Biol; 2005 Oct; 37(10):1938-47. PubMed ID: 15927519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
    Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
    Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism and novel therapeutic approaches to wasting in chronic disease.
    Ebner N; Springer J; Kalantar-Zadeh K; Lainscak M; Doehner W; Anker SD; von Haehling S
    Maturitas; 2013 Jul; 75(3):199-206. PubMed ID: 23664695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and functional effects of glutamate intake in patients with chronic obstructive pulmonary disease (COPD).
    Rutten EP; Engelen MP; Gosker H; Bast A; Cosemans K; Vissers YL; Wouters EF; Deutz NE; Schols AM
    Clin Nutr; 2008 Jun; 27(3):408-15. PubMed ID: 18433945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiologic particularities of muscle impairments in the patient with COPD].
    Gea J; Orozco-Levi M; Barreiro E
    Nutr Hosp; 2006 May; 21 Suppl 3():62-8. PubMed ID: 16768032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Global therapeutic approach of muscle dysfunction in COPD].
    Alvarez Hernández J
    Nutr Hosp; 2006 May; 21 Suppl 3():76-83. PubMed ID: 16768034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muscular disorders of the patient with scleroderma. Clinical study].
    Cywiner-Golenzer C; Lecestre MJ
    Sem Hop; 1975 Feb; 51(7):541-4. PubMed ID: 169582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress.
    Couillard A; Prefaut C
    Eur Respir J; 2005 Oct; 26(4):703-19. PubMed ID: 16204604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle wasting in chronic obstructive pulmonary disease: to bother and to measure!
    Wouters EF
    Am J Respir Crit Care Med; 2006 Jan; 173(1):4-5. PubMed ID: 16368791
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of skeletal muscle atrophy.
    Ventadour S; Attaix D
    Curr Opin Rheumatol; 2006 Nov; 18(6):631-5. PubMed ID: 17053511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.